Aurora Cannabis Inc (NASDAQ:ACB) currently has a daily average trading volume of 2.68M but it saw 1544851 shares traded in last market. With a market cap of 321.60M USD, the company’s current market price of $5.86 came rising about 1.21 while comparing to the previous closing price of $5.79. In past 52 weeks, the stock remained buoying in the range of price level as high as $9.35 and as low as $2.84.
Taking a look at 20-day trading activity of Aurora Cannabis Inc (ACB) gives us an average price of $5.06, while its current price level is -37.33% below from 52-week high level whereas it is 106.34% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $4.58 while that of 200 days or SMA-200 reads an average of $5.44. A closer look into the stock’s movement over the week reveals that its volatility is standing at 6.99% during that period while stretching the period over a month that increases to 8.09%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 60.20 which implies that the stock is in neutral territory.
Over the week, ACB’s stock price is moving -7.42% down while it is 50.26% when we observe its performance for the past one month. Year-to-date it is 37.88% up and over the past year, the stock is showing an upside performance of 49.11%.
The company is expected to be releasing its next quarterly report in March, for which analysts forecasted an EPS of 0 while estimate for next year EPS is -0.65. In next quarter, company is expected to be making quarterly sales of $102.41M as analysts are expecting the sales for current fiscal year at $343.01M and seeing the company making $383.09M in sales next year. Moreover, analysts are in estimates of $89.9M for current-quarter revenue.
Currently, Aurora Cannabis Inc’s total number of outstanding shares is 54.88M with 0.00% of that held by the insiders while 13.98% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 1.98% and return on equity (ROE) at 4.78%. It has a price to earnings ratio (P/E ratio) of 37.18 while having a 20.84 of forward P/E ratio. Stock’s beta reads 1.80. Stock has a price to book (P/B) ratio of 0.81 while price to sale or P/S ratio amounts to 1.38. Its return on asset (ROA) is 3.09% on average.
